ExcelFin Acquisition Corp.

Status: Deal Closed
U=S+W/2 W=S@11.50
IPO Proceeds, $M $230.00M
IPO Date Oct 21, 2021
CEO Joe Ragan
Left Lead UBS
IPO Cash in Trust 102.0%
SPAC Tenor 18 + 6 + 6 + 3 + 5
IPO Sector Financial

U.S. domiciled Financial Technology

IPO Geography US/Canada
Target Company Baird Medical
Deal Announced Jun 26, 2023
Deal Size, $M $279.00M
Deal Sector Healthcare
Deal Geography Asia
SEC Filings www.sec.gov
Approval Vote Sep 26, 2024
Amendment Vote Jul 24, 2024
Closing Date Oct 1, 2024
Formerly XFIN BDMD BDMDW

Sign up for Free Trial

No credit card required

Sign in for more on ExcelFin Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 48 filings and events
  • 3 underwriters
  • 2 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Jennifer Hill 55 Chairman of the Board
Joe Ragan 61 CEO and Director
Brian Sun 48 COO
Joe Ragan 59 Chief Financial Officer
Brian Sun 45 Executive Vice President
Gary Meltzer 57 Director
Neil Wolfson 56 Director
Goh Lin Piao 56 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
UBS BR 15,000,000 units
EXOS Securities 4,000,000
KeyBanc Capital Markets 1,000,000
20,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee
3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings
Oct 5, 2021 Initial S-1
Oct 15, 2021

Sign In to view filing content.

Oct 20, 2021

Sign In to view filing content.

Oct 22, 2021 424B4 IPO Prospectus
Oct 29, 2021

Sign In to view filing content.

Dec 10, 2021

Sign In to view filing content.

Mar 9, 2023

Sign In to view filing content.

Mar 24, 2023

Sign In to view filing content.

Mar 24, 2023

Sign In to view filing content.

Apr 6, 2023

Sign In to view filing content.

Apr 19, 2023

Sign In to view filing content.

Apr 20, 2023

Sign In to view filing content.

Jun 26, 2023

Sign In to view filing content.

Aug 21, 2023

Sign In to view filing content.

Sep 6, 2023

Sign In to view filing content.

Sep 26, 2023

Sign In to view filing content.

Oct 17, 2023

Sign In to view filing content.

Oct 26, 2023

Sign In to view filing content.

Nov 22, 2023

Sign In to view filing content.

Nov 28, 2023

Sign In to view filing content.

Dec 12, 2023

Sign In to view filing content.

Jan 19, 2024

Sign In to view filing content.

Jan 26, 2024

Sign In to view filing content.

Mar 11, 2024

Sign In to view filing content.

Mar 12, 2024

Sign In to view filing content.

Mar 12, 2024

Sign In to view filing content.

Mar 18, 2024

Sign In to view filing content.

Mar 18, 2024

Sign In to view filing content.

Mar 22, 2024

Sign In to view filing content.

Apr 11, 2024

Sign In to view filing content.

Apr 22, 2024

Sign In to view filing content.

Apr 25, 2024

Sign In to view filing content.

May 16, 2024

Sign In to view filing content.

Jun 12, 2024

Sign In to view filing content.

Jun 20, 2024

Sign In to view filing content.

Jun 20, 2024

Sign In to view filing content.

Jun 25, 2024

Sign In to view filing content.

Jun 27, 2024

Sign In to view filing content.

Jul 17, 2024

Sign In to view filing content.

Jul 19, 2024

Sign In to view filing content.

Jul 24, 2024

Sign In to view filing content.

Aug 12, 2024 F-4/A Amendment #6 to registration statement containing preliminary proxy for Baird Medical business combination
Aug 23, 2024

Sign In to view filing content.

Aug 26, 2024

Sign In to view filing content.

Sep 5, 2024

Sign In to view filing content.

Sep 26, 2024

Sign In to view filing content.

Sep 27, 2024

Sign In to view filing content.

Oct 1, 2024

Sign In to view filing content.

Shareholders

Sign in to view shareholders 13F filing data.